BioSpecifics Technologies Corp.
2 Righter Parkway, Suite 200
Wilmington, DE 19803
July 15, 2020
VIA EDGAR
Securities and Exchange Commission
Division of Corporation Finance
100 F Street, N.E.
Washington, D.C. 20549
Attention: Ada Sarmento
Re: | BioSpecifics Technologies Corp. |
Registration Statement on Form S-3
Filed June 26, 2020
File No. 333-239484
Ladies and Gentlemen:
Pursuant to Rule 461 under the Securities Act of 1933, as amended, BioSpecifics Technologies Corp. hereby requests acceleration of the effective date of the above referenced registration statement, as amended, so that such registration statement may become effective at 4:30 p.m. (Washington, D.C. time) on July 17, 2020, or as soon as practicable thereafter.
BIOSPECIFICS TECHNOLOGIES CORP. | ||||
By: | /s/ Joseph Truitt | |||
Name: | Joseph Truitt | |||
Title: | Chief Executive Officer |